The US Court of Appeals has finally invalidated patent protection for Teva’s multiple sclerosis drug Copaxone (glatiramer acetate injection) for...
Teva Pharmaceutical Industries Ltd.,has announced that it has received a positive outcome in the decentralized procedure for its new, three-times-a-week...
Teva Pharmaceutical Industries Ltd. and Active Biotech announced the discontinuation of higher doses of laquinimod in two ongoing studies in...